scispace - formally typeset
T

Thomas H. Schindler

Researcher at Washington University in St. Louis

Publications -  196
Citations -  8984

Thomas H. Schindler is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Coronary artery disease & Internal medicine. The author has an hindex of 34, co-authored 168 publications receiving 7794 citations. Previous affiliations of Thomas H. Schindler include University of Geneva & Johns Hopkins University School of Medicine.

Papers
More filters
Journal ArticleDOI

2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism

TL;DR: Guidelines summarize and evaluate all available evidence at the time of the writing process, on a particular issue with the aim of assisting health professionals in selecting the best management strategies for an individual patient, with a given condition, taking into account the impact on outcome.
Journal ArticleDOI

Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making.

TL;DR: The basic concepts that hold true for whatever technology measures coronary physiology directly and reliably are clarified, here focusing on positron emission tomography and its interplay with intracoronary measurements.
Journal ArticleDOI

Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health

TL;DR: Assessment of myocardial perfusion with PET has become an indispensable tool in cardiac research and remains underutilized in clinical practice, but individualized, image-guided cardiovascular therapy may likely change this paradigm in the near future.
Journal ArticleDOI

Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.

TL;DR: With the legalization of marijuana for medicinal purposes and/or recreational use in many countries, physicians should be alert to the possibility that the use of marijuana or its potent synthetic analogues might be the underlying cause of severe cardiovascular events and pathologies.